Christos Markopoulos is an expert in Oncology at National and Kapodistrian University of Athens (Greece). As of April 2026, ScienceLeadR ranks Christos Markopoulos in the top 1% of experts worldwide for Breast Diseases and Breast Neoplasms. Christos Markopoulos has authored 217 publications, the most recent in 2026, and is an investigator in 4 clinical trials. SLR score: 527 (community average: 125). How the SLR is computed.

LeadR Profile

527 ScienceLeadR Reputation 527
Network Map

Oncology

Subspecialties: Genetics - Psychology - Dermatology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Short Biography

CHRISTOS J. MARKOPOULOS, MD, MPhil (UK), PhD, FEBS, CEBS

Breast Oncoplastic Surgeon – Em. Professor of Surgery at the Medical School of the National and Kapodistrian University of Athens - Greece and Director of the Breast Unit of the Athens Medical Center in Athens.

www.markopoulos.gr

Prof. Markopoulos qualified from Athens University Medical School and specialized in GeneralSurgery. He holds a PhD from Athens University and an MPhil degree in Oncology–Breast Cancer fromUniversity of London - UK (1988). He worked as Senior Registrar at the Breast Unit of St. George’s and The Royal Marsden Hospitals inLondon (1985-1988) and as research fellow at the Ludwing Institute for Cancer Research at Sutton, UK.

He is the founder of the Hellenic Society of Breast Surgeons(2000), President (2000-2016) and head of the education, training and clinicaltrials sectionof the society.He was the President of the UEMS-EBS Division of Breast Surgery (2016-2024) and he has been an elected member of the EUSOMA Executive Committee and memberof several medical associations, including ABS, ACBS and ESSO.

Prof. Markopoulos is national coordinator / Primary Investigator in a number of international and national research projects and clinical trials and has publishedover 350 papers in peer-reviewed international and Greekmedical journals with 10,500 citations and a current h-index of 47 and i10-index of 146. He has authored (6) and edited (18) books on breastdisease and cancer, including the “European textbook of Breast Cancer management for Surgeons” (Springer-2018), official book of the EBSQ exams in Breast Surgery and the “Breast Cancer management for Surgeons – An Examination guide” (Springer-2024).

He is recipient of a number of scientific awards during congresses and honorary awards from advocacy and patients’ groups for his work with breast cancer patients.


Organizations

Career arc: 1985 - 2026

Source: PubMed

National and Kapodistrian University of Athens

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 217

Citations

Citations: 11 139 1st author: 56 Last author: 22 Unique author: 9


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Transfer Learning and Machine Learning for Training Five-Year Survival Prognostic Models in Early Breast Cancer: Development and Validation Study.
PMID 41980703 — breast neoplasms, neoplasms, machine learning, breast, learning, forests
J Med Internet Res20260
Immunohistochemical Expression of IDO and PD-L1 in Distinct Compartments of Breast Cancer Tissue: Correlation with Clinicopathological Features and Outcomes.
PMID 41976402 — cells, immunohistochemistry, breast neoplasms, lymphocytes, neoplasms, neoplasm metastasis, breast, tissues, indoleamine-pyrrole 2,3,-dioxygenase
Cancers (Basel)20260
Prognostic and predictive performance of PREDICT 2.1, PREDICT v3, and RSClin in node-negative early breast cancer: a TEAM pathology substudy.
PMID 41642493 — breast neoplasms, neoplasms, pathology, drug therapy, breast, chemotherapy
Breast Cancer Res Treat20260
Validation of minimal risk of recurrence classification by the Breast Cancer Index in early stage breast cancer.
PMID 41469392 — breast neoplasms, neoplasms, classification, breast
NPJ Breast Cancer20251
Does RSClin provide additional information over classic clinico-pathologic scores (PREDICT 2.1, INFLUENCE 2.0, CTS5)?
PMID 40633461 — genes, breast neoplasms, breast, breast diseases
Breast20252

Clinical Studies 4

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 2
Phase 3 2

By status:

Completed 3
Terminated 1

By type:

Interventional 2
Observational 2

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 0
multicentric5to9 0
multicentricup10 1

Main Topics

LeadR Networks

Main global connection map